We are live on
!
Find out more
NRD
Nebula Research & Development Portfolio holdings
AUM
$1.17B
1-Year Est. Return
15.19%
This Fund
S&P 500
This Quarter
Est. Return
+4.46%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$56.6M
AUM Growth
–
Cap. Flow
+$58.4M
Cap. Flow
% of AUM
103.16%
Top 10 Holdings %
Top 10 Hldgs %
5.7%
Holding
220
New
220
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumen
LUMN
|
+$479K |
| 2 |
HPP
Hudson Pacific Properties
HPP
|
+$445K |
| 3 |
AAT
American Assets Trust
AAT
|
+$417K |
| 4 |
Guardant Health
GH
|
+$388K |
| 5 |
Fidelity National Information Services
FIS
|
+$385K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.52% |
| 2 | Industrials | 17.55% |
| 3 | Healthcare | 15.52% |
| 4 | Consumer Discretionary | 10.4% |
| 5 | Consumer Staples | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Unum
UNM
$13.8B
| $202K | 0.36% |
+5,116
| New | +$211K |
|
|
SILK
177
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $201K | 0.35% |
+5,132
| New | +$251K |
|
|
OLO
178
DELISTED
Olo Inc
OLO
| $199K | 0.35% |
+24,370
| New | +$188K |
|
179
UiPath
PATH
$6.02B
| $198K | 0.35% |
+11,297
| New | +$171K |
|
180
A10 Networks
ATEN
$2.41B
| $194K | 0.34% |
+12,540
| New | +$191K |
|
181
Arlo Technologies
ARLO
$1.51B
| $183K | 0.32% |
+30,219
| New | +$134K |
|
182
Astronics
ATRO
$3.47B
| $183K | 0.32% |
+16,442
| New | +$184K |
|
183
Deutsche Bank
DB
$67.9B
| $174K | 0.31% |
+17,061
| New | +$204K |
|
184
Ardmore Shipping
ASC
$669M
| $167K | 0.3% |
+11,258
| New | +$177K |
|
185
Celestica
CLS
$36.6B
| $166K | 0.29% |
+12,860
| New | +$164K |
|
|
NAPA
186
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $165K | 0.29% |
+10,368
| New | +$163K |
|
187
GrafTech
EAF
$203M
| $164K | 0.29% |
+3,365
| New | +$182K |
|
|
ACH
188
Accendra Health
ACH
$247M
| $161K | 0.28% |
+11,076
| New | +$198K |
|
189
Sportradar
SRAD
$4.34B
| $154K | 0.27% |
+13,246
| New | +$154K |
|
190
Golub Capital BDC
GBDC
$3.36B
| $144K | 0.26% |
+10,651
| New | +$144K |
|
191
Newell Brands
NWL
$2.2B
| $142K | 0.25% |
+11,388
| New | +$161K |
|
192
Aurinia Pharmaceuticals
AUPH
$1.96B
| $140K | 0.25% |
+12,813
| New | +$113K |
|
193
Elanco Animal Health
ELAN
$12.7B
| $128K | 0.23% |
+13,670
| New | +$161K |
|
|
MRC
194
DELISTED
MRC Global
MRC
| $119K | 0.21% |
+12,205
| New | +$139K |
|
195
Ocular Therapeutix
OCUL
$1.89B
| $118K | 0.21% |
+22,474
| New | +$107K |
|
196
Magnite
MGNI
$2.73B
| $116K | 0.2% |
+12,485
| New | +$133K |
|
197
Uranium Energy
UEC
$4.9B
| $112K | 0.2% |
+38,974
| New | +$141K |
|
198
DocGo
DCGO
$62.2M
| $111K | 0.2% |
+12,835
| New | +$113K |
|
199
Oil States International
OIS
$512M
| $111K | 0.2% |
+13,304
| New | +$113K |
|
200
Bausch Health
BHC
$1.67B
| $110K | 0.19% |
+13,542
| New | +$109K |
|
Similar funds
SAF
GIM
CCM
PP
FC
HIP
SC
BWA
Nebula Research & Development's Q1 2023 Portfolio in Review
Q1 2023 is the first quarter with a 13F filing on record for Nebula Research & Development, which disclosed 220 positions worth $56.6M. Its ten largest holdings account for 5.7% of the portfolio.
Its largest position is Lumen: 118,738 shares worth $315K.
By sector, the portfolio is most concentrated in Technology at 19% of assets, followed by Industrials and Healthcare.
- Nebula Research & Development's largest Q1 2023 buy was Lumen: 118,738 shares worth $315K.
- Nebula Research & Development's ten largest holdings make up 5.7% of its $56.6M portfolio in Q1 2023.
- Nebula Research & Development disclosed 220 positions in Q1 2023, its first 13F filing on record.
Based on Nebula Research & Development's 13F filing for Q1 2023, filed 15 May 2023.